Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
Roswell Park Cancer Institute
University of California, San Francisco
Uppsala University
University of Washington
Minia University
University of Washington
Fudan University
Azienda Ospedaliera Universitaria Integrata Verona
University of Chicago
Rezolute